Over the 90-day window ending December 12, 2025, Immunovant's three dominant insider ownership positions are held by Chief Medical Officer Michael Geffner (217.96K shares), Chief Technology Officer Jay S Stout (200.81K shares), Chief Operating Officer Melanie Gloria (173.51K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Sciences Ltd. Roivant | 113,317,007 | 12 Dec, 2025 | |
| Peter Salzmann | Chief Executive Officer | 1,178,191 | 17 Apr, 2025 |
| Frank Torti | 835,039 | 03 Apr, 2025 | |
| Julia G. Butchko | Chief Development Officer | 440,959 | 23 Aug, 2024 |
| Eva Renee Barnett | Chief Financial Officer | 396,774 | 17 Apr, 2025 |
| William L. Macias | Chief Medical Officer | 357,353 | 21 Feb, 2025 |
| Mark S. Levine | Chief Legal Officer | 319,228 | 22 Nov, 2024 |
| Michael Geffner | Chief Medical Officer | 217,958 | 24 Oct, 2025 |
| Tiago Girao | Chief Financial Officer | 208,388 | 05 May, 2025 |
| Jay S Stout | Chief Technology Officer | 200,814 | 24 Oct, 2025 |
| Melanie Gloria | Chief Operating Officer | 173,511 | 21 Nov, 2025 |
| Tuyl Christopher Van | Chief Legal Officer | 160,743 | 03 Apr, 2025 |
| George V Migausky | 137,251 | 03 Apr, 2025 | |
| Rita Jain | Chief Medical Officer | 129,365 | 31 Mar, 2021 |
| Atul Pande | 122,851 | 03 Apr, 2025 | |
| Douglas J. Hughes | 120,773 | 03 Dec, 2025 | |
| Michael James Elliott | Chief Scientific Officer | 97,600 | 23 Mar, 2021 |
| Andrew J. Fromkin | 85,852 | 03 Dec, 2025 | |
| Connealy Pamela Yanchik | Chief Financial Officer | 46,200 | 23 Mar, 2021 |
| Robert Graham Susman | 25,016 | 05 May, 2025 | |
| Jake Bauer | 25,016 | 05 May, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 12 Dec, 2025 | Sciences Ltd. Roivant | Common Stock, $0.0001 par value per share | A | 16,666,666 | $21.00 | 113,317,007 | D | P |
| 01 Dec, 2025 | Douglas J. Hughes | Common Stock | D | 13,091 | $23.14 | 122,682 | D | S |
| 01 Dec, 2025 | Andrew J. Fromkin | Common Stock | D | 19,351 | $23.14 | 88,750 | D | S |
| 01 Dec, 2025 | Douglas J. Hughes | Common Stock | D | 1,909 | $23.96 | 120,773 | D | S |
| 01 Dec, 2025 | Andrew J. Fromkin | Common Stock | D | 2,898 | $23.95 | 85,852 | D | S |
| 20 Nov, 2025 | Melanie Gloria | Common Stock | D | 10,251 | $23.54 | 175,886 | D | S |
| 20 Nov, 2025 | Melanie Gloria | Common Stock | D | 2,375 | $23.97 | 173,511 | D | S |
| 22 Oct, 2025 | Jay S Stout | Common Stock | D | 2,520 | $19.03 | 200,814 | D | S |
| 22 Oct, 2025 | Michael Geffner | Common Stock | D | 2,595 | $19.03 | 217,958 | D | S |
| 08 Oct, 2025 | Michael Geffner | Common Stock | D | 1,272 | $16.30 | 220,553 | D | S |
| 08 Oct, 2025 | Jay S Stout | Common Stock | D | 1,585 | $16.30 | 203,334 | D | S |
| 23 Jul, 2025 | Jay S Stout | Common Stock | D | 2,805 | $18.15 | 204,919 | D | S |
| 23 Jul, 2025 | Michael Geffner | Common Stock | D | 2,385 | $18.15 | 221,825 | D | S |
| 09 Jul, 2025 | Michael Geffner | Common Stock | D | 1,160 | $17.24 | 224,210 | D | S |
| 09 Jul, 2025 | Jay S Stout | Common Stock | D | 1,519 | $17.24 | 207,724 | D | S |
| 01 May, 2025 | Tiago Girao | Common Stock | A | 208,388 | $0.00 | 208,388 | D | A |
| 01 May, 2025 | Jake Bauer | Common Stock | A | 25,016 | $0.00 | 25,016 | D | A |
| 01 May, 2025 | Jake Bauer | - | - | 25,016 | D | |||
| 01 May, 2025 | Robert Graham Susman | Common Stock | A | 25,016 | $0.00 | 25,016 | D | A |
| 23 Apr, 2025 | Michael Geffner | Common Stock | D | 2,349 | $14.79 | 225,370 | D | S |